AstraZeneca stops trial of lung cancer drug
AstraZeneca, the pharmaceutical group, has stopped a trial of an experimental medicine to treat lung cancer amid safety concerns.
Recentin, a drug that aims to starve tumours by cutting off their blood supply, was being tested for non-small cell lung cancer - the most common form of lung cancer - in a trial in Canada.
This entry was posted on Thursday, February 28th, 2008 at 10:31 am and is filed under Research. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.